September 19, 2012

The Undy 5000 5K Run/Walk, presented by Dulcolax, returned to Philadelphia for the fifth consecutive year to help raise funds for colon cancer research.

September 19, 2012

GMDC will feature its connectivity tool, GMDC*Connect Powered by Telepresence, to help facilitate more top-to-top meetings with on-site attendees and executives with tight travel schedules at its 2012 HBW Conference, which kicks off Sept. 21 in San Antonio, Texas.

September 19, 2012

A subsidiary of Johnson & Johnson is hoping to gain Food and Drug Administration approval for a new formulation of one of its drugs.

September 19, 2012

Beauty retailer Sephora launched this month at select locations its new Sephora Skincare IQ, which is in-store technology to make addressing skin care concerns faster, smarter and simpler.

September 19, 2012

Local programs in Wisconsin that help people living with diabetes are getting a big boost in funding from a Danish drug maker.

September 19, 2012

Procter & Gamble Company and the National Breast Cancer Foundation have kicked off the fifth annual Give Hope program and its “Do It For the Girls!” campaign designed to rally women to take control of their breast health, take action and create an early detection plan in the fight against breast cancer.

September 19, 2012

Revlon’s board has declared a regular dividend of approximately 16.5 cents per share on the Series A Preferred Stock for the period from July 9 through Oct. 8.

September 19, 2012

Schiff is in the process of launching its latest Move Free joint supplement — Move Free One — which combines hyaluronic acid and astaxanthin with krill oil, the source of omega-3 for its Mega Red brand.

September 19, 2012

Drug maker Vivus has released what it called the first new drug in 13 years for chronic weight management in adults.

September 18, 2012

Judging from the number of dietary supplement companies that are being snatched up by heavy-hitting suppliers in the over-the-counter space, the 5% uptick in supplement sales for the 52 weeks ended Aug. 12 is one trend that stands to continue.

September 18, 2012

Boehringer Ingelheim Pharmaceuticals has launched a drug for treating chronic obstructive pulmonary disease, the company said Tuesday.

September 18, 2012

Bounty has partnered with Fuji Senkei's new Web reality cooking contest.

September 18, 2012

Candy is a sweet spot for drug retailers. The drug channel is outperforming food and mass in total category dollar sales, according to data from the National Confectioners Association.

September 18, 2012

Similasan is one homeopathic company making a move into pediatric cough/cold.

September 18, 2012

Do you think that most consumers are using professional whitening services to brighten their smile? Think again.

September 18, 2012

The overall foot care category was relatively flat — down 0.9% — with $587.2 million in sales for the 52 weeks ended Aug. 12 across food, drug and mass (excluding Walmart), according to SymphonyIRI Group data. However, almost 2-out-of-3 foot care products sold are insoles, which bodes well for sales 
going forward. 


September 18, 2012

The Food and Drug Administration has approved a treatment for a disease that causes brittle nails.

September 18, 2012

Sales of hair spray experienced a slight lift during the 12 weeks ended July 8, according to SymphonyIRI Group, as beauty mavens continued to turn to styling products to achieve a desired look and lock it in place.


September 18, 2012

MidWest Quality Gloves has introduced a new Max Performance line of work gloves.

September 18, 2012

Heineken USA has redesigned its classic green bottle.

September 18, 2012

L'Oréal Paris has officially announced actress Lea Michele as the brand's newest ambassador.

September 18, 2012

Earlier this summer Hyland’s introduced its Leg Cramps Ointment to complement its line of homeopathic Leg Cramps tablets. Expect the leg cramp market to grow.

September 18, 2012

It’s a little hard not to say “Oh, how the mighty have fallen” when a retailer announces that it will give away for free what was once the world’s top-selling drug. But for retailers, it also makes good business sense.


September 18, 2012

Over the last few years of DSN’s coverage of the impending patent cliff and how it would affect the generic drug industry, IMS Health VP industry relations Doug Long predicted that the gradual commoditization of primary care drugs — long the lifeblood of generic drug makers — would lead to consolidation of the industry.